|
HUP0101629A2
(en)
|
1998-04-15 |
2003-03-28 |
Aventis Pharma Inc |
Process for the preparation of resin-bound cyclic peptides
|
|
US6316410B1
(en)
*
|
1999-09-22 |
2001-11-13 |
National Research Council Of Canada |
Parathyroid hormone analogues for the treatment of osteoporosis
|
|
WO2003097690A2
(en)
*
|
2002-05-16 |
2003-11-27 |
Theratechnologies Inc. |
Pth derivatives resistant to skin proteases
|
|
WO2004073587A2
(en)
*
|
2003-02-19 |
2004-09-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 1 (pthr1)
|
|
CA2529777A1
(en)
*
|
2003-07-15 |
2005-01-27 |
National Research Council Of Canada |
Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells
|
|
US7439226B2
(en)
*
|
2003-09-30 |
2008-10-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Serine protease inhibitors
|
|
MXPA06012980A
(es)
*
|
2004-05-10 |
2007-06-12 |
Nastech Pharm Co |
Composiciones y metodos para el suministro mucosal mejorado de la hormona paratiroidea.
|
|
US20060052305A1
(en)
*
|
2004-05-10 |
2006-03-09 |
Nastech Pharmaceutical Company Inc. |
Method of treating osteoporosis using intranasal parathyroid hormone
|
|
US20060127320A1
(en)
*
|
2004-05-10 |
2006-06-15 |
Nastech Pharmaceutical Company Inc. |
Method of delivering parathyroid hormone to a human
|
|
US20060052306A1
(en)
*
|
2004-05-10 |
2006-03-09 |
Nastech Pharmaceutical Company Inc. |
GRAS composition for enhanced mucosal delivery of parathyroid hormone
|
|
WO2007007325A2
(en)
|
2005-07-07 |
2007-01-18 |
Fulcrum Sp Ltd. |
Sp1 polypeptides, modified sp1 polypeptides and uses thereof
|
|
US20070173447A1
(en)
*
|
2005-10-25 |
2007-07-26 |
Nastech Pharmaceutical Company Inc. |
Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
|
|
CN101355959B
(zh)
*
|
2005-11-10 |
2013-02-27 |
密歇根理工大学管理委员会 |
黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法
|
|
US20080051332A1
(en)
*
|
2005-11-18 |
2008-02-28 |
Nastech Pharmaceutical Company Inc. |
Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
|
|
AU2007313001B2
(en)
*
|
2006-10-13 |
2012-03-22 |
Eli Lilly And Company |
Pegylated PTH as PTH receptor modulators and uses thereof
|
|
US8691760B2
(en)
|
2009-02-02 |
2014-04-08 |
Ramot At Tel-Aviv University |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
|
US8912142B2
(en)
|
2009-04-01 |
2014-12-16 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Method of regulating proliferation and differentiation of keratinocyes
|
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
|
ES2729051T3
(es)
*
|
2009-07-29 |
2019-10-30 |
Kai Pharmaceuticals Inc |
Agentes terapéuticos para reducir los niveles de hormona paratiroidea
|
|
EP2509996A1
(en)
|
2009-12-07 |
2012-10-17 |
Michigan Technological University |
Black bear parathyroid hormone and methods of using black bear parathyroid hormone
|
|
US9352000B2
(en)
|
2010-05-05 |
2016-05-31 |
Rappaport Family Institute For Research In The Medical Sciences |
Use of CCL1 in therapy
|
|
WO2011143406A2
(en)
*
|
2010-05-13 |
2011-11-17 |
The General Hospital Corporation |
Parathyroid hormone analogs and uses thereof
|
|
WO2012017439A2
(en)
|
2010-08-04 |
2012-02-09 |
Ramot At Tel-Aviv University Ltd. |
Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
|
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
|
ES2702487T3
(es)
*
|
2011-06-17 |
2019-03-01 |
Nantenergy Inc |
Líquido iónico que contiene iones sulfonato
|
|
JP6429191B2
(ja)
|
2012-03-06 |
2018-11-28 |
セレクト バイオセラピューティクス リミテッド |
アポトーシスシグナル伝達抵抗性細胞を選択する装置および方法ならびにその使用
|
|
US9695402B2
(en)
|
2013-09-17 |
2017-07-04 |
Yeda Research And Development Co. Ltd. |
ERK-derived peptides and uses thereof
|
|
WO2015114633A1
(en)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same
|
|
US20170174764A1
(en)
|
2014-03-27 |
2017-06-22 |
Yeda Research And Development Co. Ltd. |
T-cell receptor cdr3 peptides and antibodies
|
|
CN113713090B
(zh)
|
2015-02-09 |
2023-06-02 |
安特拉贝欧有限公司 |
骨质疏松症的治疗
|
|
EP3261582B1
(en)
|
2015-02-26 |
2021-01-06 |
Remodeless CV Ltd. |
Methods and compositions relating to leptin antagonists
|
|
IL274572B2
(en)
|
2015-07-16 |
2024-01-01 |
Biolinerx Ltd |
Compositions and methods for treating cancer
|
|
WO2017122209A2
(en)
|
2016-01-12 |
2017-07-20 |
Yeda Research And Development Co. Ltd. |
NF-kappaB INHIBITORS
|
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
|
EP3464322B1
(en)
|
2016-06-05 |
2023-04-05 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Novel molecules for the treatment of inflammation
|
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
|
SG11201810936VA
(en)
|
2016-12-01 |
2019-01-30 |
Univ Ramot |
Combined treatment for nerve injuries
|
|
EP3606615B1
(en)
|
2017-04-07 |
2026-01-07 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Method of straightening hair, method for maintenance of straightened hair and kit for straightening hair
|
|
US20200172604A1
(en)
|
2017-05-23 |
2020-06-04 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
|
US11660270B2
(en)
|
2017-07-20 |
2023-05-30 |
Indiana University Research And Technology Corporation |
Nanoparticle compositions
|
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
|
IL274979B2
(en)
|
2017-11-29 |
2024-07-01 |
Univ Ramot |
Methods for the prevention and treatment of neurogenic seizures
|
|
EP3785279A4
(en)
|
2018-05-31 |
2022-07-27 |
Immunity Pharma Ltd. |
COMPOSITIONS AND METHODS OF USE THEREOF IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
US12134638B2
(en)
|
2018-07-11 |
2024-11-05 |
Kahr Medical Ltd. |
SIRPalpha-4-1BBL variant fusion protein and methods of use thereof
|
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
|
US20220267409A1
(en)
|
2019-07-11 |
2022-08-25 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
|
CN115335532A
(zh)
|
2020-02-09 |
2022-11-11 |
Nlc制药有限公司 |
Sars-cov-2快速检测测试
|
|
WO2021176457A1
(en)
|
2020-03-05 |
2021-09-10 |
Ariel Scientific Innovations Ltd. |
Anti-hemorrhaging compositions
|
|
US20230127559A1
(en)
|
2020-03-16 |
2023-04-27 |
Yeda Research And Development Co. Ltd. |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with mutant p53 protein
|
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
|
WO2022064494A2
(en)
|
2020-09-23 |
2022-03-31 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating coronaviral infections
|
|
CN116635056A
(zh)
|
2020-10-07 |
2023-08-22 |
波塔力克斯有限公司 |
长效脱氧核糖核酸酶
|
|
EP4240423A1
(en)
|
2020-11-03 |
2023-09-13 |
Protalix Ltd. |
Modified uricase and uses thereof
|
|
EP4294428A1
(en)
|
2021-02-18 |
2023-12-27 |
Yeda Research and Development Co. Ltd |
Method of generating vaccines
|
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
|
WO2023031934A1
(en)
|
2021-09-02 |
2023-03-09 |
Yeda Research And Development Co. Ltd. |
Agents that target the glycine arginine-rich domain of nucleolin and uses thereof
|
|
WO2024038462A1
(en)
|
2022-08-17 |
2024-02-22 |
Yeda Research And Development Co. Ltd. |
Novel bacteria-based delivery system for tace (adam17) selective biological inhibitor
|
|
WO2024241314A1
(en)
|
2023-05-22 |
2024-11-28 |
Neomanna Ltd |
Black soldier fly protein extracts
|